Vancouver, Canada

Ester Falconer

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 24.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Ester Falconer: Innovator in Anti-Coronavirus Antibodies

Introduction

Ester Falconer is a notable inventor based in Vancouver, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies aimed at combating coronavirus-related diseases. With a total of three patents to her name, Falconer is recognized for her innovative approaches to addressing public health challenges.

Latest Patents

Ester Falconer's latest patents focus on anti-coronavirus antibodies and their methods of use. These patents include antibodies that bind to the spike proteins of SARS-CoV and SARS-CoV-2. The methods outlined in her patents are designed for treating or preventing conditions associated with SARS or COVID-19, as well as for detecting these viruses. Her work is crucial in the ongoing fight against the COVID-19 pandemic.

Career Highlights

Throughout her career, Ester Falconer has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Abcellera Biologics Inc. Her experience in these institutions has allowed her to contribute to groundbreaking research and development in the field of immunology.

Collaborations

Ester has collaborated with talented individuals such as Kathryn Westendorf and Stefanie Zentelis. These partnerships have enhanced her research efforts and have been instrumental in advancing her innovative projects.

Conclusion

Ester Falconer is a pioneering inventor whose work in anti-coronavirus antibodies is making a significant impact on public health. Her patents and collaborations reflect her commitment to innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…